human cytomegaloviru hmv herpesviru ubiquitin distribute pathogen caps sever disease immunosuppress patient infect newborn effort underway prepare effect subunit vaccine therapy include antivirus antibody howe current vaccine hamper lack inform protect immune response character cell response health individual could aid design optic therapeutic address problem determine first time repertoire glycoprotein b gb differ seroposit units fashion metres domain viral antigen determine induce neutral infect also common sever experiment current test human find reveal vast major gbspecif secret clone virus active found bind editor local within previous character domain ad map target structure genre model use identify surface expo protein two target domain amino acid aa ii discontinue built reside analysis larger panel serum post rate respect accord previous nomenclature design dom collect data contribute develop passive immune 